List view / Grid view

C. Difficile

 

news

FDA grants QIDP for C. Difficile IV treatment

25 July 2016 | By Niamh Louise Marriott, Digital Content Producer

Morphochem announced today that the U.S. FDA has designated Morphochem’s intravenous antibacterial product as a Qualified Infectious Disease Product...